S&P Pharmaceutical Company Limited - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for S&P Pharmaceutical Company Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

S&P Pharmaceutical Company Limited Formerly known as S&P Pharmaceutical Industry Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese, OTC drugs and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and biological products. These products are for cardiovascular and respiratory systems in the form of solutions and capsules. Products include Chongcaojing (an essence made from Chinese caterpillar fungus), Chongcao Shensi oral liquid, Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen), among others. Operations of the Group are carried out in the People's Republic of China.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report